ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,559Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1107

$1.51M Total Retail Price of All Prescriptions

Rank: 26 out of 1107

634 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 23,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
AMLODIPINE BESYLATE 1,125 997 1 6
LISINOPRIL 1,071 842 2 2
OMEPRAZOLE 1,015 794 3 4
PRAVASTATIN SODIUM 857 717 4 12
METFORMIN HCL ER 562 437 5 58
GABAPENTIN 556 414 6 9
FUROSEMIDE 493 444 7 7
LEVOTHYROXINE SODIUM 479 340 8 3
ATORVASTATIN CALCIUM 476 384 9 13
BISOPROLOL FUMARATE 474 420 10 136
METFORMIN HCL 454 374 11 8
MELOXICAM 429 361 12 25
SIMVASTATIN 418 311 13 5
WARFARIN SODIUM 414 373 14 15
LOSARTAN POTASSIUM 389 362 15 29
CITALOPRAM HBR 377 306 16 17
LOVASTATIN 375 348 17 55
SYNTHROID 361 297 18 70
POTASSIUM CHLORIDE 349 287 19 14
RANITIDINE HCL 330 254 20 21
ROPINIROLE HCL 310 220 21 69
METOPROLOL SUCCINATE 292 240 22 16
METOPROLOL TARTRATE 287 247 23 10
ATENOLOL 287 248 23 19
FLUTICASONE PROPIONATE 284 233 25 38
GLIMEPIRIDE 283 234 26 43
TRAZODONE HCL 252 180 27 33
BISOPROLOL-HYDROCHLOROTHIAZIDE 248 224 28 164
ALLOPURINOL 239 227 29 36
HYDROCHLOROTHIAZIDE 237 217 30 11
NEXIUM 229 201 31 18
BENAZEPRIL HCL 225 170 32 86
LACTULOSE 219 175 33 89
SERTRALINE HCL 212 165 34 20
DONEPEZIL HCL 204 184 35 32
PROAIR HFA 201 145 36 37
ZETIA 198 158 37 76
ALENDRONATE SODIUM 196 189 38 41
CRESTOR 194 171 39 23
TRAMADOL HCL 192 148 40 26
TAMSULOSIN HCL 185 163 41 30
DIGOXIN 184 183 42 52
HYDRALAZINE HCL 183 166 43 99
JANUVIA 179 148 44 60
LEVOXYL 170 143 45 268
DIOVAN 168 152 46 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 136 47 24
CARVEDILOL 162 153 47 27
INDAPAMIDE 160 160 49 183
CLOPIDOGREL 149 137 50 28
FINASTERIDE 148 118 51 130
DOXAZOSIN MESYLATE 144 139 52 92
PLAVIX 144 130 52 39
ACTOS 141 84 54 132
MIRTAZAPINE 130 111 55 61
AMITRIPTYLINE HCL 130 120 R 55 48
CHLORTHALIDONE 129 103 57 175
DICLOFENAC SODIUM 126 90 58 74
LIDODERM 123 114 59 140
LANTUS 122 114 60 49
ISOSORBIDE MONONITRATE ER 120 105 61 34
FENOFIBRATE 120 76 61 67
ADVAIR DISKUS 118 101 63 54
VERAPAMIL ER 116 90 64 113
LIPITOR 116 95 64 109
FORTICAL 113 111 66 235
HYDROCODONE-ACETAMINOPHEN 108 96 S3 67 1
SPIRIVA 105 104 68 57
NAMENDA 105 84 68 42
LOVAZA 101 76 70 101
RISPERIDONE 98 84 71 79
FAMOTIDINE 98 97 71 111
AMLODIPINE BESYLATE-BENAZEPRIL 97 88 73 77
NOVOLOG 94 52 74 127
NYSTATIN 91 75 75 110
VENTOLIN HFA 91 69 75 97
POLYETHYLENE GLYCOL 3350 89 73 77 46
TRIAMTERENE-HCTZ 89 78 77 62
SINGULAIR 89 61 77 65
BUSPIRONE HCL 88 67 80 107
AZITHROMYCIN 87 70 81 35
METOCLOPRAMIDE HCL 87 59 81 116
CELEBREX 86 77 83 85
PAROXETINE HCL 86 70 83 45
LOSARTAN-HYDROCHLOROTHIAZIDE 85 82 85 66
DILTIAZEM 24HR CD 84 84 86 126
ALBUTEROL SULFATE 84 83 86 144
CALCITONIN-SALMON 83 83 88 301
DOXYCYCLINE HYCLATE 82 60 89 128
MECLIZINE HCL 82 79 89 114
QUETIAPINE FUMARATE 80 47 91 94
FLUOXETINE HCL 80 66 91 47
MORPHINE SULFATE ER 80 45 S2 91 156
CYMBALTA 76 55 94 50
ACARBOSE 75 71 95 297
ESTRADIOL 73 20 R 96 151
MUPIROCIN 73 57 96 161
TRILIPIX 72 66 98 153
VALPROIC ACID 70 49 99 231
FELODIPINE ER 70 65 99 218
CIPROFLOXACIN HCL 68 58 101 59
LANSOPRAZOLE 65 52 102 102
CLONIDINE HCL 65 54 102 53
HYDROXYZINE HCL 63 52 R 104 162
DIOVAN HCT 63 60 104 106
PHENYTOIN SODIUM EXTENDED 62 28 106 147
MONTELUKAST SODIUM 61 42 107 118
GEMFIBROZIL 61 55 107 107
ENABLEX 60 48 109 271
GLYBURIDE 59 59 R 110 68
PIOGLITAZONE HCL 59 37 R 110 258
SYMBICORT 57 51 112 124
SEROQUEL 56 48 113 182
GLUMETZA 56 56 113 448
AVODART 56 56 113 204
DEXILANT 56 47 113 212
DOXEPIN HCL 52 39 117 180
DIVALPROEX SODIUM 51 30 118 96
COMBIVENT 51 39 118 112
CEPHALEXIN 50 38 120 81
KLOR-CON 10 50 50 120 143
QUINAPRIL HCL 50 38 120 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.